Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 Debt-to-EBITDA is 0.50 as of Mar. 2026, which is 23% below its 10-year median of 0.65. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 479 Healthcare Providers & Services companies, Pramodini Medicare ranks better than 54.49% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Pramodini Medicare's Debt-to-EBITDA or its related term are showing as below:
NSE:PRAMODINI'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.51 Med: 0.65 Max: 1.98
Current: 1.98
During the past 4 years, the highest Debt-to-EBITDA Ratio of Pramodini Medicare was 1.98. The lowest was 0.51. And the median was 0.65.
NSE:PRAMODINI's Debt-to-EBITDA is ranked better than 54.49% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs NSE:PRAMODINI: 1.98
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Pramodini Medicare Debt-to-EBITDA Related Terms
Pramodini Medicare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare Debt-to-EBITDA Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Debt-to-EBITDA
1.42
0.74
0.51
0.56
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
Debt-to-EBITDA
N/A
N/A
N/A
N/A
0.50
NSE:PRAMODINI vs HCA, THC, EHC: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Pramodini Medicare (NSE:PRAMODINI) has a Debt-to-EBITDA of 0.50 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Pramodini Medicare. This is 23% below median its historical median of 0.65. Over the past decade, Pramodini Medicare's Debt-to-EBITDA has ranged from 0.51 to 1.98. According to the industry distribution chart, Pramodini Medicare ranks #218 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Pramodini Medicare's Debt-to-EBITDA too high?
Pramodini Medicare's current Debt-to-EBITDA of 0.50 is 23% below median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 1.98. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Pramodini Medicare's value of 0.50 is 77.2% below this industry median. Based on the distribution chart, Pramodini Medicare ranks #218 out of 479 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #218 out of 479 companies for Debt-to-EBITDA. This puts Pramodini Medicare in the upper half of its industry. The industry median Debt-to-EBITDA is 2.19. Pramodini Medicare's value of 0.50 is 77.2% below this benchmark. Historically, Pramodini Medicare's own Debt-to-EBITDA has ranged from 0.51 to 1.98 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 2.19, Pramodini Medicare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pramodini Medicare's current Debt-to-EBITDA of 0.50 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Pramodini Medicare. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current Debt-to-EBITDA is 0.50, which is 23% below median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Debt-to-EBITDA of 0.50. The current Debt-to-EBITDA is 0.50, which is 23% below median its 10-year median of 0.65 and 77.2% below the Healthcare Providers & Services industry median of 2.19. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Debt-to-EBITDA is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
